MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1221 to 1240 of 166,322 approvalsPage 62 of 8317

Sugammadex Sodium Injection

Approval Number: 国药准字H20258028
Registration: Mar 5, 2025

Tranexamic Acid Injection

Approval Number: 国药准字H20258023
Registration: Mar 5, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20258025
Registration: Mar 5, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20258024
Registration: Mar 5, 2025

Citicoline Sodium Injection

Approval Number: 国药准字H20258027
Registration: Mar 5, 2025

Naloxone Hydrochloride Injection

Approval Number: 国药准字H20253487
Registration: Mar 4, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253501
Registration: Mar 4, 2025

Thiotepa Injection

Approval Number: 国药准字H20253533
Registration: Mar 4, 2025

Famotidine Injection

Approval Number: 国药准字H20253508
Registration: Mar 4, 2025

Avatrombopag Maleate tablet

Approval Number: 国药准字H20253548
Registration: Mar 4, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253514
Registration: Mar 4, 2025

Diprophylline Injection

Approval Number: 国药准字H20253499
Registration: Mar 4, 2025

Desmopressin Oral Solution

Approval Number: 国药准字H20253512
Registration: Mar 4, 2025

Agomelatine Tablets

Approval Number: 国药准字H20253553
Registration: Mar 4, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253491
Registration: Mar 4, 2025

Agomelatine Tablets

Approval Number: 国药准字H20253567
Registration: Mar 4, 2025

Tacrolimus Sustained-release Capsules

Approval Number: 国药准字H20253556
Registration: Mar 4, 2025

Valsartan and Amlodipine Tablets(I)

Approval Number: 国药准字H20253520
Registration: Mar 4, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253517
Registration: Mar 4, 2025

Sodium Bicarbonate Injection

Approval Number: 国药准字H20253516
Registration: Mar 4, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.